Delivery Order SPE2DB24D1205-SPE2DB25FCQUM
Award Date
10/15/24
Potential Completion Date
10/16/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $6,917.29 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,563,534,926 tablets of the drug Letrozole 2.5 mg. The contract has a completion date of February 5, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of up to $999,999,999.00 and a performance...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,688.02 firm fixed-price delivery order is for the supply of 90-tablet bottles of the drug Letrozole 2.5 mg. The contract has a ceiling value of $9,688.02 and an ultimate completion date of May 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,643.40 firm fixed-price delivery order is for the supply of 90-count tablets of the drug Letrozole 2.5 mg. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,581.32 firm fixed-price delivery order is for the supply of Letrozole 2.5 mg tablets, a medication used for various medical conditions. The contract has an ultimate completion date of October 23, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,966.87, is for the supply of Letrozole 2.5 mg tablets to support federal healthcare programs. The contract is a firm-fixed-price arrangement with a completion date of December 17, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DX15D3306|SPE2DX23FADCD, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $3,031.27 firm fixed-price delivery order is for the supply of 90-count tablets of the drug Letrozole 2.5 mg. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Letrozole 2.5 mg tablets. The contract has a firm fixed price of $1,347.98 and a period of performance through February 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026, which serves...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Letrozole 2.5 mg tablets. The contract has a ceiling value of $2,040.45 and is a firm fixed-price delivery order that runs through March 6, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,940.95, is for the delivery of Letrozole 2.5 mg tablets in quantities of 90 per bottle. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of April 15, 2025. The award was made on April 14, 2025, and there was no set-aside designation...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,387.11, is a delivery order to procure 4566803766 LETROZOLE 2.5 MG TABLET 30S. The contract has an ultimate completion date of December 30, 2024 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...